Newsfeeds - Spark Newswire

1 minute read

Cerus Reports US Centers For Medicare, Medicaid Services Granted Permanent Healthcare Common Procedure Coding System Level II Codes For Pathogen Reduced Crypoprecipitated Fibrinogen Complex

Today, 11:03 AM

Cerus Corporation (NASDAQ: CERS) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has granted permanent Healthcare Common Procedure Coding System (HCPCS) Level II codes for Pathogen Reduced

CERS

7 minute read

88 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:03 AM

Gainers

ABSI

1 minute read

Cerus Shares Move Higher As Traders Circulate Aug. 3-Dated Sam.gov Contract Listing For Co.’s Platelet Pathogen Reduction Sets With Dept. Of Defense, Valued At ~$259K

By Benzinga Newsdesk

Today, 11:03 AM

https://sam.gov/opp/3bca378ddace4b1594903c21c686310f/view

CERS

5 minute read

58 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 11:03 AM

Gainers

ACY

2 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 11:03 AM

ALDX

6 minute read

The Daily Biotech Pulse: Pfizer’s Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings

By Shanthi Rexaline

Today, 11:03 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3)

ABSI

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 11:03 AM

Gainers

APDN

2 minute read

14 Stocks Moving In Tuesday’s After-Hours Session

By Tyree Gorges

Today, 11:03 AM

RingCentral (NYSE: RNG) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 and FY21 EPS and sales guidance above estimates.

AKAM

1 minute read

Earnings

Recap: Cerus Q2 Earnings

By Benzinga Insights

Today, 11:03 AM

Shares of Cerus (NASDAQ:CERS) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year to ($0.09), which were in line with the estimate of ($0.09).

CERS

1 minute read

Cerus Q2 EPS $(0.09), Inline, Sales $31.48M Beat $31.48M Estimate

By Benzinga Newsdesk

Today, 11:03 AM

Cerus (NASDAQ:CERS) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $31.48 million which

CERS